AR091849A1 - Compuestos inhibidores selectivos de la cyp26a1, utiles en el tratamiento de patologias - Google Patents

Compuestos inhibidores selectivos de la cyp26a1, utiles en el tratamiento de patologias

Info

Publication number
AR091849A1
AR091849A1 ARP130102586A ARP130102586A AR091849A1 AR 091849 A1 AR091849 A1 AR 091849A1 AR P130102586 A ARP130102586 A AR P130102586A AR P130102586 A ARP130102586 A AR P130102586A AR 091849 A1 AR091849 A1 AR 091849A1
Authority
AR
Argentina
Prior art keywords
pathologies
treatment
hydrogen
cyp26a1
useful
Prior art date
Application number
ARP130102586A
Other languages
English (en)
Inventor
Rivier Michel
Feraille Gerard
Boiteau Jean
Guy-Jomard Andre
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR091849A1 publication Critical patent/AR091849A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Abstract

La presente se refiere a compuestos o a una de sus sales que responden a la fórmula general (1), a las composiciones farmacéuticas y cosméticas que contienen dichos compuestos, así como a la utilización de esos compuestos y de esas composiciones para el tratamiento de patologías. Reivindicación 2: Compuesto de acuerdo con la reivindicación 1, caracterizado porque: R¹ se selecciona en el grupo constituido por un hidrógeno, un metilo y un etilo, preferentemente, un hidrógeno; R² se selecciona en el grupo constituido por un hidrógeno, un metilo, un flúor, o un radical CF₃; R³ se selecciona en el grupo constituido por un hidrógeno, un metilo, un flúor, o un radical CF₃; y R⁴ se selecciona en el grupo constituido por un hidrógeno, un metilo y un radical CF₃.
ARP130102586A 2012-07-23 2013-07-22 Compuestos inhibidores selectivos de la cyp26a1, utiles en el tratamiento de patologias AR091849A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1257128A FR2993562B1 (fr) 2012-07-23 2012-07-23 Nouveaux composes inhibiteurs selectifs du cyp26a1 utiles dans le traitement de pathologies.

Publications (1)

Publication Number Publication Date
AR091849A1 true AR091849A1 (es) 2015-03-04

Family

ID=46889286

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130102586A AR091849A1 (es) 2012-07-23 2013-07-22 Compuestos inhibidores selectivos de la cyp26a1, utiles en el tratamiento de patologias

Country Status (5)

Country Link
US (1) US9408793B2 (es)
EP (1) EP2874999B1 (es)
AR (1) AR091849A1 (es)
FR (1) FR2993562B1 (es)
WO (1) WO2014016507A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4083029A1 (en) 2013-08-20 2022-11-02 University of Washington through its Center for Commercialization Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydroxylase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767526B1 (fr) * 1997-08-21 2002-10-04 Galderma Rech Dermatologique Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
DE3903989A1 (de) * 1989-02-10 1990-09-20 Basf Ag Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika

Also Published As

Publication number Publication date
US9408793B2 (en) 2016-08-09
EP2874999A1 (fr) 2015-05-27
EP2874999B1 (fr) 2016-08-24
WO2014016507A1 (fr) 2014-01-30
FR2993562B1 (fr) 2014-08-22
FR2993562A1 (fr) 2014-01-24
US20150190323A1 (en) 2015-07-09

Similar Documents

Publication Publication Date Title
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
NI201500167A (es) Compuestos químicos
PE20181298A1 (es) Inhibidores de bromodominio bivalentes y usos de los mismos
UY33547A (es) COMPUESTOS QUÍMICOS Bcl-2 y Bcl-XL
CU20160097A7 (es) Compuestos de imidazopirazina como inhibidores de syk
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
CU20160052A7 (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
CO6400220A2 (es) Derivados de sulfonamida
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
CY1121137T1 (el) Φαρμακευτικα σκευασματα που περιλαμβανουν ανταγωνιστες ccr3
BR112017013440A2 (pt) compostos de isoquinolina para o tratamento de hiv
BR112014028042A2 (pt) inibidores de nampt
DOP2015000170A (es) Compuestos químicos
AR094997A1 (es) Sales y formas sólidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que las comprenden y sus usos
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
UY36875A (es) Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
UY35274A (es) Compuestos y métodos para tratar infecciones bacterianas
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
UY36145A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
DOP2014000178A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
AR092971A1 (es) Inhibidores de agrecanasa
AR090806A1 (es) Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii

Legal Events

Date Code Title Description
FB Suspension of granting procedure